Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (141-150 of 298) with videos related to

Pageof 30
Sort By:
Journal of Neuropathology and Experimental Neurology|December 16, 2010
Protein aggregation in the aging retinaFrançois Leger, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2004
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeysAlbert Hsu, Daniel M Togasaki, Erwan Bezard, et al.
The European Journal of Neuroscience|April 12, 2007
Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's diseaseWassilios Meissner, Celine Guigoni, Laetitia Cirilli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 22, 2020
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's DiseaseErwan Bezard, Qin Li, Heather Hulme, et al.
Scientific Reports|April 27, 2024
In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expressionClaire Mazzocco, Coralie Genevois, Qin Li, et al.
Brain Research|May 21, 2025
Texture features of T2w magnetic resonance imaging mirror tissue changes in Parkinson's disease modelsChirine Katrib, Camille Naidji, David Devos, et al.
NPJ Parkinson'S Disease|August 1, 2024
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primatesJoanna Sikora, Sandra Dovero, Rémi Kinet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2026
High-Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System AtrophyMarie-Laure Arotcarena, Anna Delamarre, Miguel Lopez-Cuina, et al.
Plos One|December 3, 2010
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeysPierre-Olivier Fernagut, Qin Li, Sandra Dovero, et al.
Annals of Neurology|October 1, 2010
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesiaDaniella Rylander, Martin Parent, Sean S O'Sullivan, et al.
Pageof 30

Showing results (141-150 of 298) with videos related to

Sort By:
Pageof 30
Journal of Neuropathology and Experimental Neurology|December 16, 2010
Protein aggregation in the aging retinaFrançois Leger, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2004
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeysAlbert Hsu, Daniel M Togasaki, Erwan Bezard, et al.
The European Journal of Neuroscience|April 12, 2007
Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's diseaseWassilios Meissner, Celine Guigoni, Laetitia Cirilli, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 22, 2020
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's DiseaseErwan Bezard, Qin Li, Heather Hulme, et al.
Scientific Reports|April 27, 2024
In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expressionClaire Mazzocco, Coralie Genevois, Qin Li, et al.
Brain Research|May 21, 2025
Texture features of T2w magnetic resonance imaging mirror tissue changes in Parkinson's disease modelsChirine Katrib, Camille Naidji, David Devos, et al.
NPJ Parkinson'S Disease|August 1, 2024
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primatesJoanna Sikora, Sandra Dovero, Rémi Kinet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2026
High-Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System AtrophyMarie-Laure Arotcarena, Anna Delamarre, Miguel Lopez-Cuina, et al.
Plos One|December 3, 2010
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeysPierre-Olivier Fernagut, Qin Li, Sandra Dovero, et al.
Annals of Neurology|October 1, 2010
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesiaDaniella Rylander, Martin Parent, Sean S O'Sullivan, et al.
Pageof 30